
Pharmaceuticals in the Netherlands
Description
Pharmaceuticals in the Netherlands
Summary
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Dutch pharmaceuticals market registered revenues of $6.6 billion in 2023, representing a compound annual growth rate (CAGR) of 2.1% between 2018 and 2023.
- The Netherlands acquired a share of 1.8% of the European pharmaceuticals market in 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the Netherlands
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Netherlands pharmaceuticals market by value in 2023?
- What will be the size of the Netherlands pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the Netherlands's pharmaceuticals market?
Table of Contents
35 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Pfizer BV
- 8.2. Novartis AG
- 8.3. Astellas Pharma Europe Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Netherlands pharmaceuticals market value: $ billion, 2018-23
- Table 2: Netherlands pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Netherlands pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Pfizer BV: Key Facts
- Table 5: Novartis AG: Key Facts
- Table 6: Novartis AG: Annual Financial Ratios
- Table 7: Novartis AG: Key Employees
- Table 8: Astellas Pharma Europe Ltd: Key Facts
- Table 9: Astellas Pharma Europe Ltd: Key Employees
- Table 10: Netherlands Size of Population (million), 2019-23
- Table 11: Netherlands Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 12: Netherlands GDP (current prices, $ billion), 2019-23
- Table 13: Netherlands Inflation, 2019-23
- Table 14: Netherlands Consumer Price Index (absolute), 2019-23
- Table 15: Netherlands Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.